OpenEvidence, a specialized medical search engine LLM, raised $200 million led by Google Ventures at a $6 billion valuation, the New York Times reports.
Why it matters: The round followed a Google presentation that caught ad buyers' attention, as drugmakers shift spending amid DTC ad scrutiny
